Malaria News and Research

Latest Malaria News and Research

Malaria misdiagnosis: an interview with Dr Toby Leslie

Malaria is caused by a multi-staged parasite which is transmitted by the bite of infected female anopheles mosquitoes. It affects millions of people and kills more than 500,000 people throughout the world every year.

26 Jul 2012

Recent release: U.S. Census Bureau, State Department release data, maps on global HIV/AIDS

The U.S. Census Bureau on Monday launched an interactive global resource on the prevalence of HIV infection and AIDS cases and deaths, which contains 149,000 statistics, making it the "most complete of its kind in the world," according to a Census Bureau press release.

26 Jul 2012

Malaria commonly misdiagnosed and mistreated in Afghanistan

Findings published in the BMJ suggest that malaria is being significantly misdiagnosed in Afghanistan, with many patients with fever alone being given antimalarial drugs and antibiotics despite having negative laboratory results for the disease.

25 Jul 2012

Malaria misdiagnosis in parts of Asia

Substantial overdiagnosis and mistreatment of malaria is evident in south and central Asia, warns a study published on bmj.com today.

25 Jul 2012

Secretary Clinton reaffirms U.S. commitment to 'AIDS-free generation,' pledges more than $150M for global efforts

In a speech delivered at the XIX International AIDS Conference in Washington, D.C., on Monday, U.S. Secretary of State Hillary Clinton "underscored the United States' commitment to achieving an 'AIDS-free generation' and announced more than $150 million in additional funding," Politico reports.

25 Jul 2012

Recent release: Global Fund results show 3.6M people on HIV treatment under fund-supported programs

In a round-up of events from the XIX International AIDS Conference on the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Trevor DeWitt, new media communications officer for the foundation, notes that the Global Fund to Fight AIDS, Tuberculosis and Malaria on Monday released results "showing broad gains in the number of people receiving HIV treatment."

24 Jul 2012

First results from community HIV testing campaign in Uganda

A clinical study in a remote region of southwest Uganda has demonstrated the feasibility of using a health campaign to rapidly test a community for HIV and simultaneously offer prevention and diagnosis for a variety of other diseases in rural and resource-poor settings of sub-Saharan Africa.

24 Jul 2012

First Edition: July 24, 2012

Today's headlines include news from the campaign season as well as reports from the international AIDS conference currently taking place in Washington, D.C.

24 Jul 2012

BioDiem presents positive findings of their eye disease drug at international conference

Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) today announced positive results from formal studies of its BDM-E eye disease drug, presented over 21 – 22 July at the International Society for Eye Research (ISER) meeting in Berlin, Germany. The ISER convenes leading researchers and clinicians in the area of eye disease.

22 Jul 2012

New CHAIT initiative on development of novel immunological therapeutic interventions

The CHAIT initiative is a public-private partnership focusing on the development of novel immunological therapeutic interventions to achieve a 'functional HIV cure' with the ultimate goal of HIV eradication.

21 Jul 2012

Cipla, DNDi to develop ARV combination therapy for children with HIV/AIDS

On the eve of the XIX International AIDS Conference in Washington, DC, the Drugs for Neglected Diseases initiative (DNDi), a not-for-profit research and development (R&D) organization, announces a new collaboration with Indian drug manufacturer Cipla to develop and produce an improved first-line antiretroviral (ARV) combination therapy specifically adapted to meet the treatment needs of infants and toddlers living with HIV/AIDS.

21 Jul 2012

Examining challenges facing Global Fund during its reform

Optimism surrounding the science of HIV treatment and prevention "is tempered by less auspicious trends, particularly shrinking budgets for global health in the U.S. and around the world," Victoria Fan, Amanda Glassman, and Rachel Silverman of the Center for Global Development (CGD) write in the center's "Global Health Policy" blog.

20 Jul 2012

Keystone Symposia on Molecular and Cellular Biology receives Gates Foundation grant

Keystone Symposia on Molecular and Cellular Biology is pleased to announce that it has received a fourth grant from the Bill & Melinda Gates Foundation to promote discoveries that will solve urgent global health problems via support of infectious disease conferences in the "Keystone Symposia Global Health Series."

20 Jul 2012

Scientists develop simple assay to diagnose 'superparasites'

Belgian scientists of the Institute of Tropical Medicine (ITM) in Antwerp, Belgium made a breakthrough in bridging high tech molecular biology research on microbial pathogens and the needs of the poorest of the poor. After sequencing the complete genome of Leishmania donovani (a parasite causing one of the most important tropical diseases after malaria) in hundreds of clinical isolates, they identified a series of mutations specific of 'superparasites' and developed a simple assay that should allow tracking them anywhere.

20 Jul 2012

Donor nation funding for HIV remains at 2008 levels, Kaiser Family Foundation/UNAIDS analysis says

A funding analysis released on Wednesday by the Kaiser Family Foundation (KFF) and UNAIDS found that "funding to fight HIV/AIDS in low- and middle-income countries has remained flat at $7.6 billion," Politico Pro reports.

20 Jul 2012

Scientists identify inhibitors of key enzyme involved in survival of malaria parasite

An international team of scientists, led by researchers from the Department of Pediatrics at the University of California, San Diego School of Medicine, have identified the first reported inhibitors of a key enzyme involved in survival of the parasite responsible for malaria. Their findings, which may provide the basis for anti-malarial drug development, are currently published in the online version of the Journal of Medicinal Chemistry.

20 Jul 2012

BioDiem signs agreement with RMIT to create new non-influenza vaccines

Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) today announced that BioDiem has signed an agreement with The Royal Melbourne Institute of Technology (RMIT) regarding a research program that will investigate the use of BioDiem’s live attenuated influenza virus (LAIV) to create new non-influenza vaccines. Developing the potential of the LAIV technology for new indications is an important part of BioDiem’s strategy, and this research is part of the work towards that goal.

19 Jul 2012

Africa's new partnership for sustainable health development 'makes sense'

With Africa's "emerging position in the global order, ... astute African leaders are striving to ensure that this realignment delivers a new paradigm of partnership for sustainable health development -- a partnership that is led by Africa, for Africans, through African-sourced solutions," UNAIDS Executive Director Michel Sidibe writes in a Huffington Post "Impact Blog" opinion piece.

19 Jul 2012

African leaders reaffirm commitment to eliminate malaria at African Union summit

"African leaders have reaffirmed their commitment to efforts to eliminate malaria, after they were informed that unprecedented success in scaling up malaria control interventions resulted in one-third reduction of malaria deaths in African in the last decade," PANA/Afriquejet reports.

17 Jul 2012

Financial boost to malaria fight would result in beneficial gains

"[A] surge in money for insecticide-treated nets and other interventions" to fight malaria over the past decade has reduced the malaria-related death rate by 26 percent since 2000, and a "new push" to fight the disease, which killed 655,000 people in 2010, would have beneficial results, according to a report set to be released by Ray Chambers, the U.N. special envoy for malaria, an Economist editorial notes.

14 Jul 2012

Malaria News and Research

Latest Malaria News and Research

Malaria misdiagnosis: an interview with Dr Toby Leslie

Recent release: U.S. Census Bureau, State Department release data, maps on global HIV/AIDS

Malaria commonly misdiagnosed and mistreated in Afghanistan

Malaria misdiagnosis in parts of Asia

Secretary Clinton reaffirms U.S. commitment to 'AIDS-free generation,' pledges more than $150M for global efforts

Recent release: Global Fund results show 3.6M people on HIV treatment under fund-supported programs

First results from community HIV testing campaign in Uganda

First Edition: July 24, 2012

BioDiem presents positive findings of their eye disease drug at international conference

New CHAIT initiative on development of novel immunological therapeutic interventions

Cipla, DNDi to develop ARV combination therapy for children with HIV/AIDS

Examining challenges facing Global Fund during its reform

Keystone Symposia on Molecular and Cellular Biology receives Gates Foundation grant

Scientists develop simple assay to diagnose 'superparasites'

Donor nation funding for HIV remains at 2008 levels, Kaiser Family Foundation/UNAIDS analysis says

Scientists identify inhibitors of key enzyme involved in survival of malaria parasite

BioDiem signs agreement with RMIT to create new non-influenza vaccines

Africa's new partnership for sustainable health development 'makes sense'

African leaders reaffirm commitment to eliminate malaria at African Union summit

Financial boost to malaria fight would result in beneficial gains

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Malaria News and Research

Latest Malaria News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in